TrialOrphanet journal of rare diseases2017

Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.

Simon A Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.